
I have just published a paper about
in vivo corneal collagen cross-linking (CXL) (pdf download :
Reevaluating the Effectiveness of Corneal Collagen Crosslinking and Its True Biomechanical Effect in Human Eyes D Gatinel ) and I believe it is certain to trigger some controversy. It is not my intention to be a heretic, but I truly believe that
we should re-examine the in vivo benefits of the CXL procedure for keratoconus management. This illustration depicts the main lines of my argument. It gives the reader an insight into my standpoint as an avid
evidence-based physician and the
reasons for my skepticism about the procedure.